ResearchProjects

The project will develop and refine a clinical registry for emergency department opioid overdose patients exposed to xylazine and novel adulterants. The registry will integrate health records, toxicologic, serum biomarkers and clinical outcomes data.

Using qualitative interviews with people who use drugs and addiction medicine specialists, the registry’s data elements and outcomes will be refined to reflect meaningful, targeted data collection

Study aims include:

1. Creating a clinical registry for xylazine-associated overdose and comprehensive ED care;
2. Measuring xylazine and its metabolites in serum/blood and urine using laboratory and point-of-care assays; and
3. Refining registry data elements and outcomes using perspectives of individuals with knowledge of xylazine and adulterants